These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1535031

  • 1. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS, George T, Baldessarini RJ.
    Brain Res Dev Brain Res; 1992 Apr 24; 66(2):286-9. PubMed ID: 1535031
    [Abstract] [Full Text] [Related]

  • 2. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 3. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM, Joseph JA, Kochman K, Roth GS.
    Brain Res; 1987 Aug 25; 418(2):334-42. PubMed ID: 2960421
    [Abstract] [Full Text] [Related]

  • 4. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Neuropharmacology; 1994 May 25; 33(5):647-55. PubMed ID: 7936100
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA, Rowlett JK, McDougall SA, Bardo MT.
    Eur J Pharmacol; 1994 Feb 03; 252(2):225-31. PubMed ID: 8157063
    [Abstract] [Full Text] [Related]

  • 6. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
    Battaglia G, Norman AB, Hess EJ, Creese I.
    Neurosci Lett; 1986 Sep 12; 69(3):290-5. PubMed ID: 2945128
    [Abstract] [Full Text] [Related]

  • 7. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D, Di Paolo T.
    Mol Pharmacol; 1991 May 12; 39(5):659-65. PubMed ID: 1674586
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M, Lévesque D, Di Paolo T.
    Mol Pharmacol; 1992 Sep 12; 42(3):480-8. PubMed ID: 1357544
    [Abstract] [Full Text] [Related]

  • 11. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F, Hervé D, Blanc G, Glowinski J, Tassin JP.
    J Neurochem; 1992 Jul 12; 59(1):331-7. PubMed ID: 1351927
    [Abstract] [Full Text] [Related]

  • 12. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
    Henry JM, Roth GS.
    Life Sci; 1984 Aug 20; 35(8):899-904. PubMed ID: 6482680
    [Abstract] [Full Text] [Related]

  • 13. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ, Battaglia G, Norman AB, Creese I.
    Mol Pharmacol; 1987 Jan 20; 31(1):50-7. PubMed ID: 3100940
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB, Wachendorf TJ, Sanberg PR.
    Life Sci; 1989 Jan 20; 44(13):831-6. PubMed ID: 2648096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF, Waszczak BL.
    Brain Res; 1993 Jun 04; 613(1):32-42. PubMed ID: 8102308
    [Abstract] [Full Text] [Related]

  • 17. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O, Biggio G.
    Pharmacol Biochem Behav; 1990 Apr 04; 35(4):877-84. PubMed ID: 1971721
    [Abstract] [Full Text] [Related]

  • 18. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
    Qin ZH, Chen JF, Weiss B.
    J Neurochem; 1994 Feb 04; 62(2):411-20. PubMed ID: 8294904
    [Abstract] [Full Text] [Related]

  • 19. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan 04; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 20. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
    Norman AB, Battaglia G, Creese I.
    J Neurosci; 1987 May 04; 7(5):1484-91. PubMed ID: 2952771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.